Keyphrases
Vascular Smooth muscle Cell Proliferation
100%
Neointima Formation
100%
IL-1 Receptor-associated Kinase 1 (IRAK1)
100%
Carotid Injury
100%
Protein Kinase
50%
Small Interfering RNA (siRNA)
25%
Extracellular Signal-regulated Kinase
25%
U0126
25%
Balloon Injury
25%
Kinase Protein
16%
Intimal Hyperplasia
16%
Platelet-derived Growth factor-BB (PDGF-BB)
16%
P27Kip1
16%
Toll-like
16%
Proliferating Cell nuclear Antigen
16%
Extracellular Signal-regulated Kinase Activation
16%
α-smooth muscle Actin (α-SMA)
8%
Fetal Bovine Serum
8%
Immunohistochemistry
8%
Phosphorylation Reaction
8%
Vascular Smooth muscle Cells
8%
Gene-deficient Mice
8%
Western Blotting
8%
Reduced Frequency
8%
Eosin Staining
8%
Hematoxylin Staining
8%
Phosphorylated Extracellular Signal-regulated Kinase
8%
Neointimal
8%
Intimal Thickening
8%
Atherosclerotic Plaque
8%
Extracellular Signal-regulated Kinase Pathway
8%
L Protein
8%
Medicine and Dentistry
Cell Proliferation
100%
Vascular Smooth Muscle Cell
100%
Neointima
100%
Mitogen-Activated Protein Kinase
58%
Protein Kinase C
50%
Small Interfering RNA
25%
U0126
25%
Neointimal Hyperplasia
16%
Downregulation
16%
Proliferating Cell Nuclear Antigen
16%
Toll Like Receptor 4
16%
Smooth Muscle Actin
8%
Immunohistochemistry
8%
Western Blot
8%
Fetal Bovine Serum
8%
Upregulation
8%
Haematoxylin
8%
Eosin
8%
Artery Intima Proliferation
8%
Platelet Derived Growth Factor
8%
Dihydrolipoamide Dehydrogenase
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neointima
100%
Mitogen Activated Protein Kinase
58%
Protein Kinase C
50%
Small Interfering RNA
25%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
25%
Cycline
16%
Hyperplasia
16%
Toll Like Receptor 4
16%
Platelet Derived Growth Factor
8%
Western Blot
8%
Haematoxylin
8%
Eosin
8%
Smooth Muscle Actin
8%
Poloxamer
8%
Dihydrolipoamide Dehydrogenase
8%
Platelet Derived Growth Factor BB
8%